Mounjaro (Tirzepatide)
Weight Loss Injection
Tirzepatide is a once-weekly, medically supervised weight-management treatment that works by reducing appetite and improving metabolic function. It supports safe, steady weight loss and enhances outcomes for patients undergoing body-contouring procedures. While not intended for skin tightening, tirzepatide serves as an effective clinical tool to assist individuals in achieving healthier weight goals with professional guidance.
Mounjaro (Tirzepatide) -Weight Loss Solution
Mounjaro is the brand name for tirzepatide when used to treat type 2 diabetes. It is also prescribed off-label or under the name Zepbound for weight loss. Originally approved as a once-weekly injectable for type 2 diabetes, Mounjaro has gained attention for producing large, clinically significant weight loss.
Tirzepatide works by targeting two natural hormones in your body—GLP-1 and GIP. These hormones help control your appetite and how your body handles sugar and fat. By activating both GLP-1 and GIP, tirzepatide can reduce hunger, keep you feeling full longer, and support better blood sugar balance. This dual action makes it more effective for weight and sugar control than older medications that target only one hormone.
Real results backed by Science
Tirzepatide (Mounjaro) works on two hormones instead of one, which is why it can be more effective for weight loss compared to semaglutide.
In a major clinical study (SURMOUNT-5), people using tirzepatide achieved:
Average weight loss at 72 weeks
20.2%
13.7%
VS
Mounjaro
Semaglutide
Waist reduction at 72 weeks
18.4cm
VS
Mounjaro
Semaglutide
13cm
In the SURMOUNT-5 clinical study, people taking tirzepatide saw results like:
-
About 20% weight loss, compared to about 14% with semaglutide
-
Waist reduction of 18.4 cm, compared to 13 cm with semaglutide
(Results measured after 72 weeks)
A long-term, 3-year follow-up also showed that many users were able to maintain their weight loss with very little rebound, especially those without other weight-related health conditions.
However, a recent real-world study from the Cleveland Clinic found that actual weight loss outside of clinical trials is often lower. This is mainly because many patients stop the medication early or take lower doses than recommended.
Our Happy Patients
Voices of Delight: Our Patients’ Testimonials Illuminate Exceptional Experiences
FAQ
A Comprehensive Guide to Addressing Your Queries and Concerns.
